94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Med.
Sec. Intensive Care Medicine and Anesthesiology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1495160
This article is part of the Research Topic Advancing Precision Medicine in Acute Stroke Care: Personalized Treatment Strategies and Outcomes View all 17 articles
Efficacy of YL-1 hematoma crushing needle combined with hematoma drainage in intracerebral hemorrhage treatment
Provisionally accepted- 1 Department of Neurosurgery, Hui'an County Hospital and Hui'an County Hospital Affiliated to Quanzhou Medical College, Quanzhou, China
- 2 Department of Intensive Care Unit, Hui'an County Hospital and Hui'an County Hospital Affiliated to Quanzhou Medical College, Quanzhou, China
- 3 Department of Neurosurgery, The Second Affiliated Hospital of Fujian Medical University, Donghai Street, Quanzhou, China
Objective: Early craniotomy evacuation in hematoma surgery does not significantly improve the prognosis of patients with spontaneous intracerebral hemorrhage (ICH). The YL-1 hematoma crushing puncture needle, specifically designed for ICH evacuation, has an uncertain therapeutic efficacy. This study aimed to evaluate its clinical effectiveness.We retrospectively reviewed medical records of patients with ICH who underwent twist intraosseous drill needle (TIDN) surgery at our institution between September 2016 and March 2023. Clinical outcomes were analyzed. Results: The surgical group demonstrated a significantly shorter hematoma resolution time, averaging 14.71 days less than the conservative group (p < 0.001). The Barthel Index improved more in the surgical group, with an average increase of 8.214 points (p < 0.001). Seven days post-admission, the increase in Glasgow Coma Scale (GCS) scores was significantly higher in the surgical group, with an average improvement of 1.471 points (p < 0.001).Additionally, the duration of mannitol administration was significantly reduced in the surgical group (p < 0.001). Conclusion: TIDN surgery combined with hematoma drainage may serve as a viable surgical alternative for basal ganglia hemorrhage patients. This approach appears to reduce mannitol usage, mitigate craniotomy-associated risks, and promote short-term improvements in GCS scores and Barthel Index, highlighting its potential clinical benefits.
Keywords: intracerebral hemorrhage, YL-1 hematoma crushing needle, Hematoma drainage, Craniotomy, urokinase，minimally invasive surgery
Received: 12 Sep 2024; Accepted: 17 Feb 2025.
Copyright: © 2025 Chen, Chen, Sun, Huang, Hu and Zhu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Zhenyong Huang, Department of Neurosurgery, Hui'an County Hospital and Hui'an County Hospital Affiliated to Quanzhou Medical College, Quanzhou, China
Weipeng Hu, Department of Neurosurgery, The Second Affiliated Hospital of Fujian Medical University, Donghai Street, Quanzhou, China
Qiangbin Zhu, Department of Neurosurgery, The Second Affiliated Hospital of Fujian Medical University, Donghai Street, Quanzhou, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.